Your SlideShare is downloading. ×
Market Research Report : Clinical trials market in india 2014 - Press release
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Market Research Report : Clinical trials market in india 2014 - Press release

156
views

Published on

For the complete report, get in touch with us at: info@netscribes.com …

For the complete report, get in touch with us at: info@netscribes.com

Abstract:
Netscribes latest market research report titled Clinical Trials Market in India 2014 analyses how India is a potential global hub for conducting clinical trials by Indian as well as global pharmaceutical companies. Clinical trials are conducted on humans to examine the efficacy and safety of new drugs, treatments, therapies and new medical devices before launching them in the market. It is a necessary and final step for the completion of the drug development process. The market is divided into four phases - Phase I, Phase II, Phase III and Phase IV. Contract Research Organizations (CROs) are responsible for designing, monitoring, and managing clinical trials. The market is dominated by private players and foreign pharmaceutical companies.
The clinical research market in India has comparative advantage in conducting clinical trials regarding cost efficiency and a vast population suffering from acute chronic diseases. Government regulations regarding the compensation rule and approval time are hampering the market at present, but the situation is expected to improve soon. Apart from the pharma companies there are several research institutes involved in R&D of clinical trials. Increasing partnerships and changes in the regulatory environment are crucial future driving factors for this market.
Coverage
Overview of the clinical trials phases
Overview of clinical trials market India and historical and forecasted market size data over FY 2013 to FY 2018e
Overview of the number of clinical trials being conducted in India
Qualitative analysis of market drivers, challenges and government participation
Analysis of the competitive landscape and detailed profiles of major players as well as the research organizations
Overview of the strategic recommendation
Why Buy
Get a clear understanding of current market situation and future growth prospects of the clinical trials market in India
Understand your competitors strengths and weakness, strategies and prospects, and respond accordingly
Get an idea of the average cost required for conducting clinical trials in India
Position yourself to gain maximum advantage by strategizing business models with a complete understanding of the business structures and strategies of competitors

Published in: Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
156
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. FOR IMMEDIATE RELEASE Clinical Trials Market Outlook – Cost Efficiency for Conducting Clinical Trials is Fuelling Growth Netscribes, Inc. launches a report on the Clinical Trials Market in India 2014 covering a market with strong growth potential. It is a part of Netscribes’ Healthcare Series Mumbai, India – Jul 22, 2014 – Global market intelligence firm, Netscribes, Inc. released its latest report on the ‘Clinical Trials Market in India 2014’. The role of clinical trials is fundamental for any innovation in pharmaceutical industry, hence a liberal regulatory environment is required to draw investors and organizations to create and commercialize improving technologies. Netscribes’ latest market research report titled Clinical Trials Market in India 2014 analyses how India is a potential global hub for conducting clinical trials by Indian as well as global pharmaceutical companies. Clinical trials are conducted on humans to examine the efficacy and safety of new drugs, treatments, therapies and new medical devices before launching them in the market. It is a necessary and final step for the completion of the drug development process. The market is divided into four phases – Phase I, Phase II, Phase III and Phase IV. Contract Research Organizations (CROs) are responsible for designing, monitoring, and managing clinical trials. The market is dominated by private players and foreign pharmaceutical companies. The clinical research market in India has comparative advantage in conducting clinical trials regarding cost efficiency and a vast population suffering from acute chronic diseases. Government regulations regarding the compensation rule and approval time are hampering the market at present, but the situation is expected to improve soon. Apart from the pharma companies there are several research institutes involved in R&D of clinical trials. Increasing partnerships and changes in the regulatory environment are crucial future driving factors for this market. For more details on the content of each report and ordering information please contact: Phone:+91 22 4098 7600 E-Mail: info@netscribes.com About Netscribes Netscribes (www.netscribes.com ) is a pioneering knowledge consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, publishing services and customized knowledge database creation. At its core lies a true value proposition that draws upon a vast knowledge base. For more information please write to info@netscribes.com